Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
33.09 USD +0.33% Intraday chart for Spyre Therapeutics, Inc. -8.31% +53.76%
May. 15 Spyre Therapeutics, Inc. Announces Board Changes CI
May. 13 Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SPYRE THERAPEUTICS, INC.
Bio Therapeutic Drugs
+0.33%-8.31%+53.76%+878.99%-80.62% 1.33B
Neutral
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. Charts Spyre Therapeutics, Inc.
  5. Relative Strength Chart